Show simple item record

dc.creatorAjdzanović, Vladimir Z
dc.creatorMilošević, Verica Lj.
dc.creatorSpasojević, Ivan
dc.date.accessioned2022-04-05T14:37:12Z
dc.date.available2022-04-05T14:37:12Z
dc.date.issued2012
dc.identifier.issn0231-5882
dc.identifier.urihttp://rimsi.imsi.bg.ac.rs/handle/123456789/581
dc.description.abstractAdvanced age is often accompanied by glucocorticoid excess which contributes to the pathogenesis of the metabolic syndrome associated with some hemodynamic disorders. Impaired central regulation of stress hormones secretion and increased glucocorticoids/adrenal androgens ratio trigger hyperglycemia, elevated blood lipids and visceral fat accumulation, associated with hypertension and increased blood viscosity, all of which represent cardiovascular morbidity factors in this age. Finding the adequate therapeutic solutions is set as an imperative in the treatment of listed symptoms. Biologically active soy isoflavones, exhibiting estrogen- and membrane-receptor agonistic/antagonistic activity, and antioxidative and tyrosine kinase/steroidogenic enzyme inhibiting effects, appear as alternative therapeutics for various ageing-related diseases. It has been shown that soy isoflavones reduce some of the listed risk factors, while affecting the hemodynamic group of cardiovascular parameters directly, as well as indirectly via endocrine perturbations. Soy isoflavones may reverse the glucocorticoids/adrenal androgens ratio, lower serum cholesterol, slow the development of atherosclerotic plaque formation, inhibit platelet aggregation, increase cardiac contractility, but they may have diverse effects on blood viscosity and may increase triglyceride levels. Herein, we present the projection of soy isoflavones-based therapy of glucocorticoid excess and disturbed hemodynamics in advanced age, concluding that although promising, it requires the impartial approach and certain precautions.en
dc.publisherGeneral Physiol And Biophysics, Bratislava
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173009/RS//
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/173014/RS//
dc.rightsopenAccess
dc.sourceGeneral Physiology and Biophysics
dc.subjectSoy isoflavonesen
dc.subjectHemodynamicsen
dc.subjectGlucocorticoidsen
dc.subjectCardiovascular parametersen
dc.subjectAdvanced ageen
dc.titleGlucocorticoid excess and disturbed hemodynamics in advanced age: the extent to which soy isoflavones may be beneficialen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage374
dc.citation.issue4
dc.citation.other31(4): 367-374
dc.citation.rankM23
dc.citation.spage367
dc.citation.volume31
dc.identifier.doi10.4149/gpb_2012_041
dc.identifier.fulltexthttp://rimsi.imsi.bg.ac.rs/bitstream/id/788/578.pdf
dc.identifier.pmid23255662
dc.identifier.wos000311981300002
dc.type.versionpublishedVersion


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record